POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IGJ_B_DGXB228_1 (IGG2A-KAPPA 26-10 FAB (LIGHT CHAIN) IGG2A-KAPPA 26-10 FAB (HEAVY CHAIN))	2qqh	COMPLEMENT COMPONENT C8 ALPHA CHAIN (Homo sapiens)	5 / 10	TYR A 311 THR A 441 TYR A 142 ASN A 181 TYR A 180	None	1.25A	19.22 18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	1qmn	ALPHA-1-ANTICHYMOTRY PSIN (Homo sapiens)	5 / 12	LEU A 306 LEU A 303 ALA A  34 PHE A  96 LEU A 103	None	1.23A	20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	2gpv	ESTROGEN-RELATED RECEPTOR GAMMA (Homo sapiens)	5 / 12	LEU A 342 LEU A 345 ALA A 431 VAL A 432 LEU A 301	OHT  A 500 ( 4.7A) OHT  A 500 (-4.3A) OHT  A 500 (-4.3A) None None	1.27A	22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	3woy	CLIP-ASSOCIATING PROTEIN 2 (Homo sapiens)	5 / 12	LEU A  99 LEU A 113 ALA A 156 VAL A 160 LEU A 216	None	1.16A	21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	4e44	CENTROMERE PROTEIN S CENTROMERE PROTEIN X (Homo sapiens)	5 / 12	LEU B  74 CYH A  58 ALA B  49 VAL B  46 PHE B  10	None	1.28A	14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	4gmj	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 7 (Homo sapiens)	5 / 12	LEU A1266 LEU A1286 ALA A1261 CYH B 148 LEU B 147	None	1.16A	22.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	4s15	NUCLEAR RECEPTOR ROR-ALPHA (Homo sapiens)	5 / 12	GLN A 289 CYH A 323 ALA A 330 PHE A 391 HIS A 484	4D8  A 601 ( 2.7A) 4D8  A 601 ( 4.0A) 4D8  A 601 (-3.1A) 4D8  A 601 ( 4.5A) None	0.89A	53.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	4s15	NUCLEAR RECEPTOR ROR-ALPHA (Homo sapiens)	9 / 12	GLN A 289 LEU A 295 CYH A 323 ALA A 330 MET A 368 ALA A 371 VAL A 379 PHE A 391 CYH A 396	4D8  A 601 ( 2.7A) None 4D8  A 601 ( 4.0A) 4D8  A 601 (-3.1A) 4D8  A 601 (-4.0A) 4D8  A 601 ( 4.0A) None 4D8  A 601 ( 4.5A) 4D8  A 601 ( 4.7A)	0.60A	53.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	4u1r	ATP-DEPENDENT 6-PHOSPHOFRUCTOKINAS E, PLATELET TYPE (Homo sapiens)	5 / 12	LEU A 757 LEU A 761 ALA A  45 VAL A  46 LEU A 131	None	0.94A	16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	4xwh	ALPHA-N-ACETYLGLUCOS AMINIDASE (Homo sapiens)	5 / 12	LEU A 299 LEU A 296 ALA A 244 CYH A 405 LEU A 383	None	1.29A	15.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5c1b	TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE (Homo sapiens)	5 / 12	LEU A 242 ALA A 310 ALA A 345 VAL A 343 PHE A 290	None	1.27A	15.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5c4t	NUCLEAR RECEPTOR ROR-GAMMA (Homo sapiens)	11 / 12	GLN A 286 LEU A 287 LEU A 292 CYH A 320 ALA A 327 ALA A 368 VAL A 376 PHE A 388 CYH A 393 LEU A 396 HIS A 479	None None None GOL  A 607 ( 4.0A) None None None GOL  A 607 ( 4.5A) None None None	0.68A	99.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5c4t	NUCLEAR RECEPTOR ROR-GAMMA (Homo sapiens)	11 / 12	GLN A 286 LEU A 287 LEU A 292 CYH A 320 ALA A 327 MET A 365 ALA A 368 VAL A 376 PHE A 388 CYH A 393 LEU A 396	None None None GOL  A 607 ( 4.0A) None None None None GOL  A 607 ( 4.5A) None None	0.68A	99.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5c4t	NUCLEAR RECEPTOR ROR-GAMMA (Homo sapiens)	5 / 12	LEU A 292 PHE A 388 CYH A 393 LEU A 396 HIS A 479	None GOL  A 607 ( 4.5A) None None None	1.11A	99.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5hdt	SISTER CHROMATID COHESION PROTEIN PDS5 HOMOLOG B (Homo sapiens)	6 / 12	LEU A 945 LEU A 998 ALA A 958 MET A 940 ALA A 941 VAL A 991	None	1.46A	11.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5jtw	COMPLEMENT C4-A (Homo sapiens)	5 / 12	LEU B1088 LEU B1022 ALA B1148 VAL B1306 LEU B1132	None	1.22A	16.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5k1c	WD REPEAT-CONTAINING PROTEIN 48 (Homo sapiens)	5 / 12	CYH B 109 ALA B 104 ALA B  48 VAL B  78 LEU B 113	None	1.16A	18.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	6ar2	SARCOLEMMAL MEMBRANE-ASSOCIATED PROTEIN (Homo sapiens)	5 / 12	ALA A   6 PHE A  17 CYH A  48 LEU A  51 HIS A  55	None	1.30A	15.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	6b5c	KATANIN P60 ATPASE-CONTAINING SUBUNIT A-LIKE 1 (Homo sapiens)	5 / 12	LEU A 245 ALA A 356 VAL A 354 PHE A 293 LEU A 194	None	1.18A	16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	1dle	COMPLEMENT FACTOR B (Homo sapiens)	3 / 3	TRP A 237 VAL A  66 ARG A  81	None	0.87A	21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	1hxm	GAMMA-DELTA T-CELL RECEPTOR (Homo sapiens)	3 / 3	TRP A  37 VAL A  13 ARG A 120	None	0.95A	18.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	1ni6	HEME OXYGENASE 1 (Homo sapiens)	3 / 3	TRP A 101 VAL A 115 ARG A 113	None	0.98A	19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	2kkq	MYOTILIN (Homo sapiens)	3 / 3	TRP A  49 VAL A  27 ARG A 110	None	0.66A	18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	2wd9	ACYL-COENZYME A SYNTHETASE ACSM2A, MITOCHONDRIAL (Homo sapiens)	3 / 3	TRP A 277 VAL A 111 ARG A 148	None	0.88A	17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	2yd3	RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE S (Homo sapiens)	3 / 3	TRP A 168 VAL A 146 ARG A 228	None	0.92A	19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	2yl2	ACETYL-COA CARBOXYLASE 1 (Homo sapiens)	3 / 3	TRP A 246 VAL A 542 ARG A 604	None	0.94A	19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	3a5k	TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1 (Homo sapiens)	3 / 3	TRP A 179 VAL A  49 ARG A  47	None	0.97A	21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	3up1	INTERLEUKIN-7 RECEPTOR SUBUNIT ALPHA (Homo sapiens)	3 / 3	TRP A 158 VAL A 117 ARG A 120	None None GOL  A 906 ( 4.5A)	0.78A	22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	3zys	DYNAMIN-1 (Homo sapiens)	3 / 3	TRP C 108 VAL C  88 ARG C  86	None	0.69A	20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	4hq6	ACETYL-COA CARBOXYLASE 2 (Homo sapiens)	3 / 3	TRP A 351 VAL A 648 ARG A 710	None	0.93A	18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	4wd4	HEME OXYGENASE 1 (Homo sapiens)	3 / 3	TRP A 101 VAL A 115 ARG A 113	None	0.85A	22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	4wk7	A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS 4 (Homo sapiens)	3 / 3	TRP A 404 VAL A 348 ARG A 318	None	0.75A	21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	5a3f	DYNAMIN 3 (Homo sapiens)	3 / 3	TRP A 612 VAL A 592 ARG A 590	None	0.83A	16.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	5c4t	NUCLEAR RECEPTOR ROR-GAMMA (Homo sapiens)	3 / 3	TRP A 317 VAL A 361 ARG A 367	None	0.40A	99.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	5ogs	WD REPEAT AND HMG-BOX DNA-BINDING PROTEIN 1 (Homo sapiens)	3 / 3	TRP A 544 VAL A 448 ARG A 456	None	0.92A	18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	6al5	B-LYMPHOCYTE ANTIGEN CD19 (Homo sapiens)	3 / 3	TRP A  52 VAL A  28 ARG A 277	None	0.76A	14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_A_DGXA1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	6axf	RAS GUANYL-RELEASING PROTEIN 2 (Homo sapiens)	3 / 3	TRP A 206 VAL A 354 ARG A 351	None	0.82A	22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	1z6t	APOPTOTIC PROTEASE ACTIVATING FACTOR 1 (Homo sapiens)	5 / 12	LEU A 415 VAL A 395 LEU A 487 LEU A 473 HIS A 468	None	1.35A	17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	2vo1	CTP SYNTHASE 1 (Homo sapiens)	5 / 12	LEU A 130 ALA A 129 VAL A 125 PHE A 163 LEU A 209	None	1.28A	20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	3ahr	ERO1-LIKE PROTEIN ALPHA (Homo sapiens)	5 / 12	LEU A 415 ALA A 446 ALA A 314 VAL A 318 LEU A 329	None	1.28A	20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	3feo	MBT DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	CYH A 303 ALA A 243 VAL A 245 PHE A 285 LEU A 281	None	1.32A	20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	3rfe	PLATELET GLYCOPROTEIN IB BETA CHAIN (Homo sapiens)	5 / 12	TRP A  21 ALA A  52 VAL A  12 LEU A  42 LEU A  61	None	1.30A	20.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	4s15	NUCLEAR RECEPTOR ROR-ALPHA (Homo sapiens)	5 / 12	GLN A 289 CYH A 323 ALA A 330 LEU A 394 HIS A 484	4D8  A 601 ( 2.7A) 4D8  A 601 ( 4.0A) 4D8  A 601 (-3.1A) 4D8  A 601 ( 4.5A) None	0.98A	53.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	4s15	NUCLEAR RECEPTOR ROR-ALPHA (Homo sapiens)	6 / 12	GLN A 289 LEU A 295 ALA A 330 ALA A 371 VAL A 379 LEU A 394	4D8  A 601 ( 2.7A) None 4D8  A 601 (-3.1A) 4D8  A 601 ( 4.0A) None 4D8  A 601 ( 4.5A)	1.36A	53.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	4s15	NUCLEAR RECEPTOR ROR-ALPHA (Homo sapiens)	9 / 12	GLN A 289 LEU A 295 CYH A 323 ALA A 330 MET A 368 ALA A 371 VAL A 379 PHE A 391 LEU A 394	4D8  A 601 ( 2.7A) None 4D8  A 601 ( 4.0A) 4D8  A 601 (-3.1A) 4D8  A 601 (-4.0A) 4D8  A 601 ( 4.0A) None 4D8  A 601 ( 4.5A) 4D8  A 601 ( 4.5A)	0.46A	53.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5c1b	TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE (Homo sapiens)	5 / 12	LEU A 242 ALA A 310 ALA A 345 VAL A 343 PHE A 290	None	1.26A	15.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5c4t	NUCLEAR RECEPTOR ROR-GAMMA (Homo sapiens)	10 / 12	GLN A 286 LEU A 292 CYH A 320 ALA A 327 MET A 365 ALA A 368 VAL A 376 PHE A 388 LEU A 391 LEU A 396	None None GOL  A 607 ( 4.0A) None None None None GOL  A 607 ( 4.5A) None None	0.61A	99.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5c4t	NUCLEAR RECEPTOR ROR-GAMMA (Homo sapiens)	11 / 12	GLN A 286 LEU A 292 TRP A 317 CYH A 320 ALA A 327 ALA A 368 VAL A 376 PHE A 388 LEU A 391 LEU A 396 HIS A 479	None None None GOL  A 607 ( 4.0A) None None None GOL  A 607 ( 4.5A) None None None	0.52A	99.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5c4t	NUCLEAR RECEPTOR ROR-GAMMA (Homo sapiens)	6 / 12	LEU A 287 TRP A 317 PHE A 388 LEU A 391 LEU A 396 HIS A 479	None None GOL  A 607 ( 4.5A) None None None	1.17A	99.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5hdt	SISTER CHROMATID COHESION PROTEIN PDS5 HOMOLOG B (Homo sapiens)	5 / 12	LEU A 998 ALA A 958 MET A 940 ALA A 941 VAL A 991	None	1.25A	11.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5k1c	WD REPEAT-CONTAINING PROTEIN 48 (Homo sapiens)	5 / 12	CYH B 109 ALA B 104 ALA B  48 VAL B  78 LEU B 113	None	1.15A	18.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_1 (NUCLEAR RECEPTOR ROR-GAMMA)	5lst	ATP-DEPENDENT DNA HELICASE Q4 (Homo sapiens)	5 / 12	LEU A 937 ALA A 587 VAL A 627 LEU A 596 LEU A 577	None	1.11A	18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	1kcw	CERULOPLASMIN (Homo sapiens)	3 / 3	LEU A 786 VAL A 777 ARG A 766	None	0.87A	12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	1wao	SERINE/THREONINE PROTEIN PHOSPHATASE 5 (Homo sapiens)	3 / 3	LEU 1 223 VAL 1 334 ARG 1 371	None	0.56A	19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	2ass	S-PHASE KINASE-ASSOCIATED PROTEIN 2 (Homo sapiens)	3 / 3	LEU B2100 VAL B2123 ARG B2126	None	0.78A	23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	2jy6	UBIQUILIN-1 (Homo sapiens)	3 / 3	LEU B 554 VAL B 545 ARG B 562	None	0.81A	10.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	2q9g	CYTOCHROME P450 46A1 (Homo sapiens)	3 / 3	LEU A 120 VAL A 253 ARG A 251	None	0.84A	20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	2vac	TWINFILIN-2 (Homo sapiens)	3 / 3	LEU A  73 VAL A  57 ARG A  26	None	0.83A	17.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	2xa0	APOPTOSIS REGULATOR BCL-2 (Homo sapiens)	3 / 3	LEU A 119 VAL A 162 ARG A 164	None	0.83A	19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	3h68	SERINE/THREONINE-PRO TEIN PHOSPHATASE 5 (Homo sapiens)	3 / 3	LEU A 223 VAL A 334 ARG A 371	None	0.73A	22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	3j9f	POLIOVIRUS RECEPTOR (Homo sapiens)	3 / 3	LEU 7 103 VAL 7  31 ARG 7 104	None	0.75A	20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	3nbi	RECQ-MEDIATED GENOME INSTABILITY PROTEIN 1 (Homo sapiens)	3 / 3	LEU A 157 VAL A  95 ARG A 133	None	0.63A	19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	3q2r	GLIOMA PATHOGENESIS-RELATED PROTEIN 1 (Homo sapiens)	3 / 3	LEU A  56 VAL A  38 ARG A  45	None	0.91A	21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	4red	5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-1 (Homo sapiens)	3 / 3	LEU A 162 VAL A 137 ARG A 140	None	0.86A	20.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	5c4t	NUCLEAR RECEPTOR ROR-GAMMA (Homo sapiens)	3 / 3	LEU A 287 VAL A 361 ARG A 367	None	0.30A	99.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	5jcp	ARF-GAP WITH RHO-GAP DOMAIN, ANK REPEAT AND PH DOMAIN-CONTAINING PROTEIN 3,LINKER,TRANSFORMIN G PROTEIN RHOA (Homo sapiens; synthetic construct)	3 / 3	LEU B1023 VAL B1087 ARG B1028	None	0.81A	18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	5jjx	SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T-CELLS 3 (Homo sapiens)	3 / 3	LEU A 337 VAL A 364 ARG A 370	None None UNX  A 402 ( 4.0A)	0.90A	23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	5lfn	CHONDROADHERIN (Homo sapiens)	3 / 3	LEU A 173 VAL A 221 ARG A 174	None	0.82A	23.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B0W_B_DGXB1_2 (NUCLEAR RECEPTOR ROR-GAMMA)	5ohk	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 30,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 30,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 30 (Homo sapiens)	3 / 3	LEU A 127 VAL A 442 ARG A 457	None	0.69A	21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	1hup	MANNOSE-BINDING PROTEIN (Homo sapiens)	5 / 12	GLN A 113 LEU A 106 GLU A 150 PHE A 119 GLY A 111	None	1.18A	10.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	2r17	VACUOLAR PROTEIN SORTING-ASSOCIATED PROTEIN 35 (Homo sapiens)	5 / 12	LEU C 579 PHE C 584 GLY C 587 ALA C 591 PHE C 606	None	1.12A	15.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	3ohm	1-PHOSPHATIDYLINOSIT OL-4,5-BISPHOSPHATE PHOSPHODIESTERASE BETA-3 (Homo sapiens)	5 / 12	LEU B 464 LEU B 315 GLY B 461 ALA B 436 LEU B 354	None	1.04A	22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4kt1	R-SPONDIN-1 (Homo sapiens)	5 / 12	ASP E  85 LEU E  64 GLU E  65 GLY E  82 ALA E 104	None	1.18A	6.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4qj4	1-PHOSPHATIDYLINOSIT OL 4,5-BISPHOSPHATE PHOSPHODIESTERASE BETA-3 (Homo sapiens)	5 / 12	LEU B 464 LEU B 315 GLY B 461 ALA B 436 LEU B 354	None	1.24A	21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	6azp	MYELOPEROXIDASE (Homo sapiens)	5 / 12	GLN A 506 LEU A 557 LEU A 527 GLU A 567 PHE A 237	None	1.18A	6.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	1g3m	ESTROGEN SULFOTRANSFERASE (Homo sapiens)	4 / 4	ASN A 130 VAL A 136 THR A 260 ILE A 259	None	1.48A	14.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	1yz4	DUAL SPECIFICITY PHOSPHATASE-LIKE 15 ISOFORM A (Homo sapiens)	4 / 4	ASN A 128 VAL A  55 THR A  97 ILE A  98	None	1.26A	10.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	1yz4	DUAL SPECIFICITY PHOSPHATASE-LIKE 15 ISOFORM A (Homo sapiens)	4 / 4	ASN A 128 VAL A  61 THR A  97 ILE A  98	None	1.37A	10.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	2g6z	DUAL SPECIFICITY PROTEIN PHOSPHATASE 5 (Homo sapiens)	4 / 4	ASN A 303 VAL A 230 THR A 272 ILE A 273	None	1.25A	10.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	2vx2	ENOYL-COA HYDRATASE DOMAIN-CONTAINING PROTEIN 3 (Homo sapiens)	4 / 4	ASN A  58 VAL A  93 THR A 233 ILE A 236	None	1.46A	13.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	3f81	DUAL SPECIFICITY PROTEIN PHOSPHATASE 3 (Homo sapiens)	4 / 4	ASN A 163 VAL A   9 THR A 133 ILE A 136	None	1.34A	10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4d61	EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR GTP-BINDING SUBUNIT ERF3A (Homo sapiens)	4 / 4	ASN i 490 VAL i 271 THR i 284 ILE i 285	None	1.11A	17.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	5dpt	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING FAMILY M MEMBER 1, GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN-LIKE 1,GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN-LIKE 1 (Homo sapiens)	4 / 4	ASN A 105 VAL A  64 THR A  90 ILE A  91	None	1.37A	9.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	5jh5	LYSINE-SPECIFIC DEMETHYLASE 2B (Homo sapiens)	4 / 4	ASN A1108 VAL A1155 THR A1134 ILE A1136	None	1.49A	15.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	5lsp	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 4	ASN A 686 VAL A 626 THR A 582 ILE A 583	None	1.44A	12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	6apx	MALTOSE-BINDING PERIPLASMIC PROTEIN,DUAL SPECIFICITY PROTEIN PHOSPHATASE 1 (Escherichia coli; Homo sapiens)	4 / 4	ASN A1298 VAL A1225 THR A1267 ILE A1268	None	1.23A	21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	6c90	EXOSOME RNA HELICASE MTR4,EXOSOME RNA HELICASE MTR4 (Homo sapiens)	4 / 4	ASN A 196 VAL A 216 THR A 228 ILE A 231	None	1.10A	9.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	3ohm	1-PHOSPHATIDYLINOSIT OL-4,5-BISPHOSPHATE PHOSPHODIESTERASE BETA-3 (Homo sapiens)	5 / 12	LEU B 464 LEU B 315 GLY B 461 ALA B 436 LEU B 354	None	1.04A	22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4bb9	GLUCOKINASE REGULATORY PROTEIN (Homo sapiens)	5 / 12	GLU A 424 LEU A 416 LEU A 397 ALA A 437 PHE A 453	None	1.30A	21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4kt1	R-SPONDIN-1 (Homo sapiens)	5 / 12	ASP E  85 LEU E  64 GLU E  65 GLY E  82 ALA E 104	None	1.18A	6.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4qj4	1-PHOSPHATIDYLINOSIT OL 4,5-BISPHOSPHATE PHOSPHODIESTERASE BETA-3 (Homo sapiens)	5 / 12	LEU B 464 LEU B 315 GLY B 461 ALA B 436 LEU B 354	None	1.24A	21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4qok	MEL5 TCR CHAIN BETA (Homo sapiens)	5 / 12	LEU E  21 LEU E 103 GLY E 108 ALA E   9 PHE E  88	None	1.31A	12.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	5y3r	DNA-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (Homo sapiens)	5 / 12	GLU C1760 LEU C1939 LEU C1752 GLU C1993 PHE C1900	None	1.19A	13.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	6azp	MYELOPEROXIDASE (Homo sapiens)	5 / 12	GLN A 506 LEU A 557 LEU A 527 GLU A 567 PHE A 237	None	1.18A	6.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	1g3m	ESTROGEN SULFOTRANSFERASE (Homo sapiens)	4 / 4	ASN A 130 VAL A 136 THR A 260 ILE A 259	None	1.48A	14.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	1yz4	DUAL SPECIFICITY PHOSPHATASE-LIKE 15 ISOFORM A (Homo sapiens)	4 / 4	ASN A 128 VAL A  55 THR A  97 ILE A  98	None	1.26A	10.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	1yz4	DUAL SPECIFICITY PHOSPHATASE-LIKE 15 ISOFORM A (Homo sapiens)	4 / 4	ASN A 128 VAL A  61 THR A  97 ILE A  98	None	1.37A	10.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	2g6z	DUAL SPECIFICITY PROTEIN PHOSPHATASE 5 (Homo sapiens)	4 / 4	ASN A 303 VAL A 230 THR A 272 ILE A 273	None	1.25A	10.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	2vx2	ENOYL-COA HYDRATASE DOMAIN-CONTAINING PROTEIN 3 (Homo sapiens)	4 / 4	ASN A  58 VAL A  93 THR A 233 ILE A 236	None	1.46A	13.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	3f81	DUAL SPECIFICITY PROTEIN PHOSPHATASE 3 (Homo sapiens)	4 / 4	ASN A 163 VAL A   9 THR A 133 ILE A 136	None	1.34A	10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4d61	EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR GTP-BINDING SUBUNIT ERF3A (Homo sapiens)	4 / 4	ASN i 490 VAL i 271 THR i 284 ILE i 285	None	1.11A	17.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	5dpt	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING FAMILY M MEMBER 1, GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN-LIKE 1,GAMMA-AMINOBUTYRIC ACID RECEPTOR-ASSOCIATED PROTEIN-LIKE 1 (Homo sapiens)	4 / 4	ASN A 105 VAL A  64 THR A  90 ILE A  91	None	1.37A	9.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	5jh5	LYSINE-SPECIFIC DEMETHYLASE 2B (Homo sapiens)	4 / 4	ASN A1108 VAL A1155 THR A1134 ILE A1136	None	1.48A	15.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	5lsp	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	4 / 4	ASN A 686 VAL A 626 THR A 582 ILE A 583	None	1.44A	12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	6apx	MALTOSE-BINDING PERIPLASMIC PROTEIN,DUAL SPECIFICITY PROTEIN PHOSPHATASE 1 (Escherichia coli; Homo sapiens)	4 / 4	ASN A1298 VAL A1225 THR A1267 ILE A1268	None	1.23A	21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	6c90	EXOSOME RNA HELICASE MTR4,EXOSOME RNA HELICASE MTR4 (Homo sapiens)	4 / 4	ASN A 196 VAL A 216 THR A 228 ILE A 231	None	1.10A	9.11